Skip to main content

PEOPLE: Silicon Genetics Hires New Marketing VP; GCI s Dougherty Leaves for Drug Developer

This update serves to clarify a misstatement of fact. Michael Pellini, CEO of Genomics Collaborative, will not become COO of the company following Michael Dougherty's departure. Instead, he will assume the title of president and CEO. GenomeWeb regrets the error.

 

NEW YORK, Nov. 13-Silicon Genetics appointed Kevin Wandryk as vice president of marketing and business development, the company said today.

 

He was previously in marketing at the internet B-to-B software companies Quova and AdKnowledge, and had spent 10 years at Adobe Systems.

 

Silicon Genetics, based in Redwood City, Calif., is  a bioinformatics company that builds gene expression anlysis software.

 


 

Genomics Collaborative president and chief operating officer Michael Dougherty has joined Adolor as senior vice president of commercial operations, the company said on Nov. 7.

 

Dougherty joined GCI in January 2001. Prior to that, he spent seven years at Magainin Pharmaceuticals, now called Genaera Corporation, where he was eventually promoted to CEO.

 

GCI chief executive officer Michael Pellini, who originally joined the company in July 1999, will now also take on the role of president.

 

Adolor is a drug-development company focusing on treatments for pain.

 


 

Promoted? Changing jobs? GenomeWeb wants to know. E-mail Kathleen McGowan at [email protected] to appear in PEOPLE, a roundup of personnel comings and goings in genomics, that appears every Wednesday.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.